<DOC>
	<DOCNO>NCT00658775</DOCNO>
	<brief_summary>The purpose study investigate efficacy ( ie , heal symptom relief ) safety Rabeprazole Extended-Release ( RAB ER ) 50 mg versus Esomeprazole ( ESO ) 40 mg treatment moderate severe erosive Gastroesophageal Reflux Disease ( eGERD ) .</brief_summary>
	<brief_title>Rabeprazole Extended-Release , 50 mg , Versus Esomeprazole , 40 mg , Healing Symptomatic Relief Moderate Severe Erosive Gastroesophageal Reflux Disease ( GERD )</brief_title>
	<detailed_description>This multicenter , randomize , double-blind , double-dummy , parallel-group study . Subjects meet inclusion/exclusion criterion randomly assign 1 2 treatment group , Rabeprazole Extended-Release ( RAB ER ) 50 mg Esomeprazole ( ESO ) 40 mg treatment moderate severe erosive Gastroesophageal Reflux Disease ( eGERD ) .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>KEY INCLUSION CRITERIA : 1 . Male female , age 18 75 year . 2 . History GERD symptoms least 3 month immediately screen . 3 . Heartburn least 2 day week least 1 month screening . 4 . Esophageal erosion LA Grades C D base EGD take within 14 day prior enrollment . 5 . Subjects H. pylori negative base screen test . 6 . Females either nonchildbearing potential childbearing potential . Females childbearing potential must negative pregnancy test prior randomization . Female subject childbearing potential must agree use medically acceptable method contraception . 7 . Subjects must able read , write , understand language symptom diary . KEY EXCLUSION CRITERIA : 1 . Current history esophageal motility disorder . 2 . Current history Barrett 's esophagus . 3 . Current esophageal stricture esophagitis ( know suspect due etiology GERD infection medication ) . 4 . Current history ZollingerEllison syndrome acid hypersecretory condition , current gastric duodenal ulcer . 5 . Current history cancer , exception fully excise skin basal cell carcinoma . 6 . Inflammatory bowel disease . 7 . Unstable diabetes mellitus . 8 . History esophageal , gastric duodenal surgery except simple suture ulcer . 9 . Subjects require daily use nonsteroidal antiinflammatory drug ( NSAIDs ) , oral steroid ( &gt; = 20 mg/day prednisone equivalent ) , aspirin ( &gt; 325 mg/day ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>GERD</keyword>
	<keyword>erosive GERD</keyword>
	<keyword>erosive esophagitis</keyword>
</DOC>